ASH Pocket Guides
ASH has developed a series of brief, evidence-based pocket guides to help physicians provide quality care to patients. The guides cover such topics as thrombocytopenia in pregnancy, heparin-induced thrombocytopenia, red blood cell transfusion, anticoagulant dosing and management, and von Willebrand disease.
The pocket guides are available as a mobile application for iOS and Android devices and as a mobile-friendly website. Free printed copies are also available to order.
Get the ASH Pocket Guides App
Get interactive versions of all the Society's clinical pocket guides right on your iOS or Android device. In addition to the pocket guides content, the app includes tools to aid in clinical decision making, including: bleeding score and 4Ts calculators; calculators for initial and chronic warfarin dosing; and interactive algorithms for the diagnosis and management of HIT and VWD.
Download for iOS Download for Android
View the Pocket Guides App on the Web
The pocket guides mobile app is also available as a mobile-friendly website. Please note: An active internet connection is required for web access.
Access the web version of the app
Download or Order the Pocket Guides
Venous Thromboembolism (VTE)
Primary Prophylaxis of Venous Thromboembolism (VTE) in Patients with Cancer
This pocket guide includes key recommendations on the prevention of VTE in patients with cancer from the American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer, published in Blood Advances.
Treatment of Venous Thromboembolism (VTE) in Patients with Cancer
This pocket guide includes key recommendations on the treatment of VTE in patients with cancer from the American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer, published in Blood Advances.
Management of Anticoagulation TherapyThis pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, published in Blood Advances.
Venous Thromboembolism (VTE) in the Context of Pregnancy
This pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy, available in Blood Advances.
Heparin-Induced Thrombocytopenia (HIT)
This pocket guide includes key recommendations on the diagnosis and management of HIT from the 2018 American Society of Hematology (ASH) Clinical Practice Guidelines for Management of VTE: HIT, published in Blood Advances.
Sickle Cell Disease
Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management
This pocket guide includes key recommendations from the American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease, available soon in Blood Advances.
Health Maintenance and Management of Chronic Complications of Sickle Cell Disease
Presented by ASH in 2014, adapted from the National Heart, Lung, and Blood Institute's Evidence Based Management of Sickle Cell Disease: Expert Panel Report, 2014
Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease
Presented by ASH in 2014, adapted from the National Heart, Lung, and Blood Institute's Evidence Based Management of Sickle Cell Disease: Expert Panel Report, 2014
Transfusion Support
This pocket guide includes key recommendations from the American Society of Hematology 2020 guidelines for the management of sickle cell disease: transfusion therapy, published in Blood Advances.
Thrombocytopenia
Management of Immune Thrombocytopenia (ITP)
This pocket guide includes key recommendations from the American Society of Hematology 2019 guideline for immune thrombocytopenia, available soon Blood Advances
Heparin-Induced Thrombocytopenia (HIT)
This pocket guide includes key recommendations on the diagnosis and management of HIT from the 2018 American Society of Hematology (ASH) Clinical Practice Guidelines for Management of VTE: HIT, published in Blood Advances.
Thrombocytopenia in Pregnancy
Presented by ASH in 2013, adapted from Gernsheimer T, James AH, Stasi R, How I treat thrombocytopenia in pregnancy. Blood. 2013;121(1):38-47; The ASH 2011 evidence-based practice guideline for immune thrombocytopenia; and other sources
Malignant
Initial Diagnostic Workup of Acute Leukemia
Presented by ASH and the College of American Pathology (CAP) in 2017, adapted from Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Archives of Pathology & Laboratory Medicine. 2017.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Presented by ASH in 2016, adapted in part from Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: International Myeloma Working Group consensus perspective risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121-1127
Transfusion
Red Blood Cell Transfusion
Presented by ASH in 2016, adapted in part from Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025-2035
Von Willebrand Disease
von Willebrand Disease
This pocket guide includes key recommendations from the ASH ISTH NHF WFH 2021 guidelines for diagnosis of VWD, published in Blood Advances and the ASH ISTH NHF WFH 2021 guidelines for management of VWD, published in Blood Advances.
All Pocket Guides
Order a printed copy of each of the currently available ASH pocket guides.
To see a list of conflicts of interest for all pocket guide authors, please click here.
ASH has developed a series of brief, evidence-based pocket guides to help physicians provide quality care to patients. The guides cover such topics as thrombocytopenia in pregnancy, heparin-induced thrombocytopenia, red blood cell transfusion, anticoagulant dosing and management, and von Willebrand disease.
The pocket guides are available as a mobile application for iOS and Android devices and as a mobile-friendly website. Free printed copies are also available to order.
Get the ASH Pocket Guides App
Get interactive versions of all the Society's clinical pocket guides right on your iOS or Android device. In addition to the pocket guides content, the app includes tools to aid in clinical decision making, including: bleeding score and 4Ts calculators; calculators for initial and chronic warfarin dosing; and interactive algorithms for the diagnosis and management of HIT and VWD.
Download for iOS Download for Android
View the Pocket Guides App on the Web
The pocket guides mobile app is also available as a mobile-friendly website. Please note: An active internet connection is required for web access.
Access the web version of the app
Download or Order the Pocket Guides
Venous Thromboembolism (VTE)
Primary Prophylaxis of Venous Thromboembolism (VTE) in Patients with Cancer
This pocket guide includes key recommendations on the prevention of VTE in patients with cancer from the American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer, published in Blood Advances.
Treatment of Venous Thromboembolism (VTE) in Patients with Cancer
This pocket guide includes key recommendations on the treatment of VTE in patients with cancer from the American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer, published in Blood Advances.
This pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, published in Blood Advances.
Venous Thromboembolism (VTE) in the Context of Pregnancy
This pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy, available in Blood Advances.
Heparin-Induced Thrombocytopenia (HIT)
This pocket guide includes key recommendations on the diagnosis and management of HIT from the 2018 American Society of Hematology (ASH) Clinical Practice Guidelines for Management of VTE: HIT, published in Blood Advances.
Sickle Cell Disease
Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management
This pocket guide includes key recommendations from the American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease, available soon in Blood Advances.
Health Maintenance and Management of Chronic Complications of Sickle Cell Disease
Presented by ASH in 2014, adapted from the National Heart, Lung, and Blood Institute's Evidence Based Management of Sickle Cell Disease: Expert Panel Report, 2014
Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease
Presented by ASH in 2014, adapted from the National Heart, Lung, and Blood Institute's Evidence Based Management of Sickle Cell Disease: Expert Panel Report, 2014
Transfusion Support
This pocket guide includes key recommendations from the American Society of Hematology 2020 guidelines for the management of sickle cell disease: transfusion therapy, published in Blood Advances.
Thrombocytopenia
Management of Immune Thrombocytopenia (ITP)
This pocket guide includes key recommendations from the American Society of Hematology 2019 guideline for immune thrombocytopenia, available soon Blood Advances
Heparin-Induced Thrombocytopenia (HIT)
This pocket guide includes key recommendations on the diagnosis and management of HIT from the 2018 American Society of Hematology (ASH) Clinical Practice Guidelines for Management of VTE: HIT, published in Blood Advances.
Thrombocytopenia in Pregnancy
Presented by ASH in 2013, adapted from Gernsheimer T, James AH, Stasi R, How I treat thrombocytopenia in pregnancy. Blood. 2013;121(1):38-47; The ASH 2011 evidence-based practice guideline for immune thrombocytopenia; and other sources
Malignant
Initial Diagnostic Workup of Acute Leukemia
Presented by ASH and the College of American Pathology (CAP) in 2017, adapted from Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Archives of Pathology & Laboratory Medicine. 2017.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Presented by ASH in 2016, adapted in part from Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: International Myeloma Working Group consensus perspective risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121-1127
Transfusion
Red Blood Cell Transfusion
Presented by ASH in 2016, adapted in part from Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025-2035
Von Willebrand Disease
von Willebrand Disease
This pocket guide includes key recommendations from the ASH ISTH NHF WFH 2021 guidelines for diagnosis of VWD, published in Blood Advances and the ASH ISTH NHF WFH 2021 guidelines for management of VWD, published in Blood Advances.
All Pocket Guides
Order a printed copy of each of the currently available ASH pocket guides.
To see a list of conflicts of interest for all pocket guide authors, please click here.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission